Precision Imaging to Evaluate Kaposi Sarcoma
NCT: NCT06898203 · NOT_YET_RECRUITING
Brief Summary
AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.
Frequently Asked Questions
What is Precision Imaging to Evaluate Kaposi Sarcoma?
Precision Imaging to Evaluate Kaposi Sarcoma is a clinical trial registered under NCT06898203. Current status: NOT_YET_RECRUITING.
What is the status of NCT06898203?
The current status of NCT06898203 (Precision Imaging to Evaluate Kaposi Sarcoma) is: NOT_YET_RECRUITING.
When did Precision Imaging to Evaluate Kaposi Sarcoma start?
Precision Imaging to Evaluate Kaposi Sarcoma started on 2026-05-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.